MedPath

PSMA PET-CT Accurately Detects Prostate Cancer Spread

The FDA approved Ga-68 PSMA-11 for PET imaging in prostate cancer, enhancing detection of metastases. A trial showed PSMA PET-CT more accurately detects metastases than standard CT and bone scans, influencing treatment strategies. Despite its higher accuracy and lower radiation, PSMA PET-CT's broader use and cost implications remain under study.


Reference News

PSMA PET-CT Accurately Detects Prostate Cancer Spread

The FDA approved Ga-68 PSMA-11 for PET imaging in prostate cancer, enhancing detection of metastases. A trial showed PSMA PET-CT more accurately detects metastases than standard CT and bone scans, influencing treatment strategies. Despite its higher accuracy and lower radiation, PSMA PET-CT's broader use and cost implications remain under study.

© Copyright 2025. All Rights Reserved by MedPath